E.N.T
📑 Journal Club Articles
Erythropoietin and retinopathy of prematurity: a retrospective cohort study in Japan, 2008-2018.
Fukui K, Ito Y, Kokubo M, Nakanishi H, Hirano S, Kusuda S, Ito S, Isayama T; Neonatal Research Network of Japan.J Perinatol. 2024 Mar 21. doi: 10.1038/s41372-024-01929-z. Online ahead of print.PMID: 38514743
Cumulative risk factors contributing to hearing loss in preterm infants.
Chant K, Bitner-Glindzicz M, Marlow N.Arch Dis Child Fetal Neonatal Ed. 2023 Sep;108(5):464-470. doi: 10.1136/archdischild-2022-324331. Epub 2022 Dec 23.PMID: 36564163
Nitkin CR, Bamat NA, Lagatta J, DeMauro SB, Lee HC, Patel RM, King B, Slaughter JL, Campbell JP, Richardson T, Lewis T.JAMA Ophthalmol. 2022 Nov 1;140(11):1085-1094. doi: 10.1001/jamaophthalmol.2022.3788.
Srivatsa B, Hagan JL, Clark RH, Kupke KG.J Pediatr. 2022 Aug;247:46-52.e4. doi: 10.1016/j.jpeds.2022.03.057. Epub 2022 Apr 12.
Hypertension in neonates treated with intravitreal bevacizumab for retinopathy of prematurity.
Twitty G, Weiss M, Bazacliu C, O'Mara K, Mowitz ME.J Perinatol. 2021 Jun;41(6):1426-1431. doi: 10.1038/s41372-021-01021-w. Epub 2021 Mar 8.PMID: 33686120
Trends in Retinopathy of Prematurity Screening and Treatment: 2008-2018.
Prakalapakorn SG, Greenberg L, Edwards EM, Ehret DEY.Pediatrics. 2021 Jun;147(6):e2020039966. doi: 10.1542/peds.2020-039966. Epub 2021 May 11.PMID: 33975923